dc.contributor.author |
Bitzer, Michael |
|
dc.date.accessioned |
2024-12-02T09:26:09Z |
|
dc.date.available |
2024-12-02T09:26:09Z |
|
dc.date.issued |
2024 |
|
dc.identifier.issn |
1598-2998 |
|
dc.identifier.uri |
http://hdl.handle.net/10900/159232 |
|
dc.language.iso |
en |
de_DE |
dc.publisher |
Seoul : Korean Cancer Association |
de_DE |
dc.relation.uri |
http://dx.doi.org/10.4143/crt.2023.1197 |
de_DE |
dc.subject.ddc |
610 |
de_DE |
dc.title |
Global Expanded Access Program for Pemigatinib in Patients with Previously Treated Locally Advanced or Metastatic Cholangiocarcinoma and Fibroblast Growth Factor Receptor Gene Alterations |
de_DE |
dc.type |
Article |
de_DE |
utue.quellen.id |
20241001000000_00923 |
|
utue.publikation.seiten |
847-855 |
de_DE |
utue.personen.roh |
Lindley, Anouk |
|
utue.personen.roh |
Prager, Gerald |
|
utue.personen.roh |
Bitzer, Michael |
|
utue.personen.roh |
Burn, Timothy C. |
|
utue.personen.roh |
Lihou, Christine F. |
|
utue.personen.roh |
Croft, Elisabeth |
|
dcterms.isPartOf.ZSTitelID |
Cancer Research and Treatment |
de_DE |
dcterms.isPartOf.ZS-Issue |
3 |
de_DE |
dcterms.isPartOf.ZS-Volume |
56 |
de_DE |
utue.fakultaet |
04 Medizinische Fakultät |
de_DE |